Market Overview:

The Women’s Health Diagnostics Market size was USD 20.3 billion in 2022. Covid-19's impacts have been unprecedented and staggering on a global scale, with the pandemic leading to positive demand shocks for the women’s health diagnostics market across all domains and regions. Between 2021 and 2030, the market is projected to grow at a CAGR of 6.9%, from USD 19.2 billion in 2021 to USD 36.3 billion in 2031 according to a new report by Intellectual Market Insights Research. The sudden rise in CAGR is attributed to this market growth and demand returning to the pre-pandemic level once the pandemic is over.

The women's health diagnostics market refers to the segment of the healthcare industry that is dedicated to the diagnosis and treatment of health conditions specific to women. This includes diagnostic tests, procedures, and devices that are designed to detect or monitor conditions such as breast cancer, cervical cancer, pregnancy-related complications, menopause, and reproductive health issues. The scope of the women's health diagnostics market includes a range of products and services, including laboratory tests, imaging tests, and diagnostic devices. These products are used by healthcare professionals to diagnose and monitor a wide range of women's health issues, from routine screenings and check-ups to more complex conditions that require specialized care.

The women's health diagnostics market is a rapidly growing segment of the healthcare industry, driven in part by increasing awareness of women's health issues and advances in medical technology. As more women seek out healthcare services and demand greater access to innovative diagnostic tools, the women's health diagnostics market is expected to continue to expand in the coming years.

The Women's Health Diagnostics market research report comprises a thorough examination of the current and future scenario of this industry vertical. The research highlights major trends and opportunities, as well as challenges, for various segments and sub-segments, while broadening the company horizon. The study report also includes extensive information based on past and present patterns across several industry verticals to help find various expansion prospects. Throughout the forecast period, several estimations regarding market share, market size, and industry growth rate are presented. The research includes information on competitive analysis as well as consumption habits and pricing strategies depending on the Women's Health Diagnostics market.

Scope of Women's Health Diagnostics Market Report:

A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global Women's Health Diagnostics Market. On the basis of historic growth analysis and current scenario of Women's Health Diagnostics market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Women's Health Diagnostics market. This further helps users with their developmental strategy.

This report examines all the key factors influencing growth of global Women's Health Diagnostics market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Women's Health Diagnostics market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, pricing strategies, innovation possibilities and much more.

The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

Women's Health Diagnostics Market Drivers:

Increasing prevalence of chronic and infectious diseases:

Women are at a higher risk of developing chronic and infectious diseases, which is driving the demand for diagnostic tests and devices that can accurately detect these conditions early. For example, breast cancer is one of the most common types of cancer in women, and early detection is crucial for successful treatment. Diagnostic tools such as mammography, breast ultrasound, and breast MRI are used to detect breast cancer, and advances in technology have led to improved accuracy and reduced false-positive results. Similarly, cervical cancer is another common cancer in women, and regular Pap tests are recommended to screen for abnormal cells in the cervix that can lead to cancer. More recently, HPV testing has been recommended as an alternative or additional screening tool for cervical cancer, and advances in molecular diagnostics have led to the development of highly accurate HPV tests.

In addition to cancer, women are also at higher risk for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and HPV. Diagnostic tests for STIs can help detect these infections early and allow for prompt treatment, which can prevent complications such as infertility or cervical cancer. Additionally, women are more likely than men to develop autoimmune diseases such as lupus, multiple sclerosis, and rheumatoid arthritis, which can be difficult to diagnose and manage without accurate diagnostic tests. Overall, the increasing prevalence of chronic and infectious diseases in women underscores the need for accurate and reliable diagnostic tests and devices. As a result, the women's health diagnostics market is expected to continue to grow in the coming years.

Women's Health Diagnostics Market Trends:

Personalized medicine:

Personalized medicine, also known as precision medicine, is an emerging trend in healthcare that aims to tailor treatments to individual patients based on their unique genetic, environmental, and lifestyle factors. In women's health, personalized medicine is being used to develop more effective and targeted diagnostic tests and treatments for conditions such as breast cancer and ovarian cancer.

For example, advances in genetic testing have led to the development of multi-gene panels that can identify inherited mutations that increase the risk of breast and ovarian cancer. This information can be used to personalize screening and surveillance strategies for women at high risk of these cancers. Additionally, targeted therapies that are tailored to the specific genetic mutations present in a patient's cancer are becoming increasingly common in the treatment of breast and ovarian cancer.

In addition to cancer, personalized medicine is also being applied to other women's health conditions such as endometriosis and polycystic ovary syndrome (PCOS). For example, genetic testing can help identify women with a higher risk of developing endometriosis or PCOS, allowing for earlier intervention and management. Overall, personalized medicine is a promising trend in women's health diagnostics that has the potential to improve outcomes and reduce the burden of disease. As more research is conducted and technologies continue to advance, personalized medicine is expected to play an increasingly important role in the diagnosis and treatment of women's health conditions.

Women's Health Diagnostics Market Restraining Factors:

High cost of diagnostic tests and devices:

One of the main restraints in the women's health diagnostics market is the high cost of diagnostic tests and devices. Many of the diagnostic tests used in women's health, such as mammography, breast MRI, and HPV testing, are relatively expensive and may not be covered by insurance for all women. This can lead to disparities in access to diagnostic testing based on factors such as income and geographic location.

In addition, the cost of developing and commercializing new diagnostic tests and devices is often high, which can limit the availability of innovative technologies. Companies may also face regulatory and reimbursement challenges when bringing new diagnostic tests and devices to market, which can further increase costs and limit availability.

The high cost of diagnostic tests and devices can also impact patient compliance with screening recommendations. Women who cannot afford to pay for diagnostic tests or who face high out-of-pocket costs may be less likely to undergo recommended screenings, which can lead to delayed diagnosis and poorer health outcomes. Overall, the high cost of diagnostic tests and devices is a significant restraint in the women's health diagnostics market that can limit access to care and impact patient outcomes. Addressing this issue will require a combination of policy and regulatory changes, as well as technological advances that reduce the cost of developing and manufacturing diagnostic tests and devices.

Report Coverage:

The report will cover the qualitative and quantitative data on the global women’s health diagnostics market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations:

Key Players Strategies in the Market:

Quest Diagnostics announced in July 2020 that it had acquired the remaining 60% stake in Blueprint Genetics, a provider of genetic testing for reproductive health, cardiovascular diseases, and cancer. This acquisition will help Quest Diagnostics expand its women's health diagnostic offerings.

Becton, Dickinson and Company (BD) announced in June 2020 that it had received FDA clearance for its BD Onclarity HPV assay, which is used for detecting 14 high-risk human papillomavirus (HPV) types in women. This test can help in the early detection of cervical cancer.

Women's Health Diagnostics Market Players Analysis:

Here is a list of some of the companies profiled in the Women's Health Diagnostics Market:

• Quest Diagnostics
• Hologic, Inc.
• Siemens Healthineers
• Abbott Laboratories
• Roche Diagnostics
• GE Healthcare
• Becton, Dickinson and Company
• PerkinElmer, Inc.
• Fujifilm Holdings Corporation
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Sysmex Corporation

Women's Health Diagnostics Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2022-2031 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Women's Health Diagnostics Market Segmentation Analysis:

By Device Type

Biopsy Devices: These are medical instruments used to obtain tissue samples from the breast, cervix, uterus, ovaries, or other parts of the female reproductive system for diagnostic purposes. Examples include core needle biopsy, vacuum-assisted biopsy, and surgical biopsy devices.

Imaging & Monitoring Systems:

1. Ultrasound Devices: These use high-frequency sound waves to create images of internal organs and tissues in the female reproductive system. They are commonly used for prenatal and gynecological examinations.
2. Mammography Systems: These use low-dose X-rays to create images of the breast tissue, and are primarily used for breast cancer screening and diagnosis.
3. MRI Systems: These use magnetic fields and radio waves to produce detailed images of the internal structures of the female reproductive system, and are often used for breast cancer diagnosis and staging.
4. Others: This category includes other imaging and monitoring devices such as hysteroscopes, colposcopes, and fetal monitors.

Kits & Reagents: These are diagnostic tools used to detect biomarkers or genetic material related to specific women's health conditions, such as breast cancer, cervical cancer, and prenatal disorders. Examples include HPV testing kits, BRCA gene testing kits, and pregnancy test kits.

Consumables & Accessories: This category includes a range of disposable medical supplies and accessories used in diagnostic procedures, such as needles, catheters, syringes, and biopsy forceps. It also includes contrast agents and other consumables used in imaging tests.

By Test Type

Breast cancer testing: This involves various imaging and biopsy techniques used for early detection, diagnosis, and monitoring of breast cancer, such as mammography, ultrasound, magnetic resonance imaging (MRI), and biopsy devices.

Cervical cancer testing: This includes screening tests like Pap smear, HPV test, and colposcopy, which are used for the detection and prevention of cervical cancer.

Prenatal genetic screening & carrier testing: These tests are used during pregnancy to screen for genetic disorders and identify if the fetus has inherited any abnormal genes or mutations from the parents.

Pregnancy testing: These tests are used to confirm the pregnancy status of a woman by detecting the presence of the human chorionic gonadotropin (hCG) hormone in the urine or blood.

Fertility & ovulation testing: These tests are used to determine a woman's fertility status and help in identifying the fertile period for conception, such as ovulation predictor kits and basal body temperature monitoring.

Infection disease testing: This includes various tests used for the detection and diagnosis of infections that affect women's health, such as sexually transmitted infections (STIs), urinary tract infections (UTIs), and viral infections like hepatitis B and C.

Others: This segment includes other tests used for women's health diagnostics, such as bone density testing, menopause testing, and hormone level testing.

By End User

Hospital: Hospitals are expected to hold a significant share of the market owing to the availability of advanced diagnostic technologies, trained healthcare professionals, and a large patient pool.

Diagnostic Laboratories & Imaging Centers: The diagnostic laboratories and imaging centers segment is anticipated to witness significant growth due to the rising prevalence of chronic diseases among women and the increasing demand for accurate diagnosis and treatment.

Specialty Clinics: Specialty clinics, such as gynecology and obstetrics clinics, cater specifically to women's healthcare needs and are expected to witness substantial growth during the forecast period.

Others: Other end users include home healthcare settings, research and academic institutes, and ambulatory surgical centers, among others.

The report also helps in understanding Global Women's Health Diagnostics Market dynamics, structure by analyzing the market segments, and project the Global Women's Health Diagnostics Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Women's Health Diagnostics Market make the report investor’s guide.

Global Women's Health Diagnostics Market Regional Analysis:

North America accounted for the highest xx% market share in terms of revenue in the Women's Health Diagnostics market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Women's Health Diagnostics. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Women's Health Diagnostics companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Women's Health Diagnostics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Regional Snapshots:

North America: North America is expected to dominate the women's health diagnostics market due to the presence of a large number of key players, high healthcare expenditure, and increasing awareness about women's health. The United States is expected to be the largest contributor to the regional market growth.

Europe: Europe is expected to hold a significant share of the women's health diagnostics market due to the increasing prevalence of chronic diseases, rising geriatric population, and increasing demand for personalized medicine. The United Kingdom, Germany, and France are expected to be the major contributors to the regional market growth.

Asia Pacific: Asia Pacific is expected to witness the fastest growth in the women's health diagnostics market due to the increasing focus on healthcare infrastructure development, rising disposable income, and increasing prevalence of chronic diseases among women. China, India, and Japan are expected to be the major contributors to the regional market growth.

Latin America: Latin America is expected to witness significant growth in the women's health diagnostics market due to the increasing government initiatives for improving healthcare infrastructure, rising disposable income, and increasing prevalence of chronic diseases. Brazil, Mexico, and Argentina are expected to be the major contributors to the regional market growth.

Middle East and Africa: The Middle East and Africa region is expected to witness moderate growth in the women's health diagnostics market due to the increasing awareness about women's health, rising healthcare expenditure. Saudi Arabia, South Africa, and the UAE are expected to be the major contributors to the regional market growth.

Women's Health Diagnostics Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report:

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.

The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Industry Developments:

• In March 2021, Hologic, Inc. announced that it had received CE Mark approval for its Aptima BV and Aptima CV/TV assays, which are used for detecting bacterial vaginosis (BV) and vaginitis, respectively. The company aims to expand its women's health diagnostic portfolio through this approval.
• In February 2021, Roche Diagnostics announced that it had received FDA clearance for its Elecsys AMH Plus immunoassay, which is used for measuring anti-Müllerian hormone (AMH) levels in women. This test is used for assessing a woman's ovarian reserve and can help in the diagnosis of infertility.
• In November 2020, Siemens Healthineers announced that it had received FDA clearance for its Atellica IM B·R·A·H·M·S PCT assay, which is used for measuring procalcitonin levels in women. This test is used for aiding in the diagnosis of sepsis in pregnant women.
• In September 2020, Abbott Laboratories announced that it had received FDA approval for its Advia Centaur HER-2/neu assay, which is used for detecting human epidermal growth factor receptor 2 (HER2) protein levels in women with breast cancer. This test can help in determining the appropriate treatment options for these patients.

Key Questions:

• How much the global Women's Health Diagnostics Market valued?
• Which region has the largest share in 2021 for the global Women's Health Diagnostics Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of Women's Health Diagnostics Market:

• Historic year: 2018- 2021
• Base year: 2022
• Forecast: 2023 to 2031
• Representation of Market revenue in USD Million

Women's Health Diagnostics Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: